APO Research

APO RESEARCH · REPORT

Drug-coated Balloon (DCB)

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Product & engineering

Understand the product.

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Selected research

Market Analysis & Forecast

Global Drug-coated Balloon (DCB) Market Analysis and Forecast 2026-2032

Market perspective

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

The global Drug-coated Balloon (DCB) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Europe market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug-coated Balloon (DCB) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Drug-coated Balloon (DCB) include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Drug-coated Balloon (DCB), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug-coated Balloon (DCB), also provides the sales of main regions and countries. Of the upcoming market potential for Drug-coated Balloon (DCB), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug-coated Balloon (DCB) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug-coated Balloon (DCB) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Drug-coated Balloon (DCB) sales, projected growth trends, production technology, application and end-user industry.

Drug-coated Balloon (DCB) Segment by Company

Medtronic

Boston Scientific

Becton Dickinson

Biotronik

B. Braun

Philips

Abbott

Eurocor

Yinyi Biotech

Lepu Medical

Grand Pharma

Acotec Scientific

Shenqi Medical

MicroPort

Zylox-Tonbridge Medical

Zhejiang Barty Medical

Drug-coated Balloon (DCB) Segment by Type

Coronary DCB

Peripheral DCB (FP)

Peripheral DCB (BTK)

Drug-coated Balloon (DCB) Segment by Application

Dialysis Access (AVF/AVG)

Femoropopliteal (FP)

Below-the-Knee (BTK)

Drug-coated Balloon (DCB) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Drug-coated Balloon (DCB) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-coated Balloon (DCB) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug-coated Balloon (DCB) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Coronary DCB Major Manufacturers Table 3. Peripheral DCB (FP) Major Manufacturers Table 4. Peripheral DCB (BTK) Major Manufacturers Table 5. Global Drug-coated Balloon (DCB) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Dialysis Access (AVF/AVG) Major Manufacturers Table 7. Femoropopliteal (FP) Major Manufacturers Table 8. Below-the-Knee (BTK) Major Manufacturers Table 9. Drug-coated Balloon (DCB) Industry Trends Table 10. Drug-coated Balloon (DCB) Industry Drivers Table 11. Drug-coated Balloon (DCB) Industry Opportunities and Challenges Table 12. Drug-coated Balloon (DCB) Industry Restraints Table 13. Global Drug-coated Balloon (DCB) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Drug-coated Balloon (DCB) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Drug-coated Balloon (DCB) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2021-2026) Table 17. Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2027-2032) Table 18. Global Drug-coated Balloon (DCB) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Drug-coated Balloon (DCB) Sales by Region (2021-2026) & (k units) Table 20. Global Drug-coated Balloon (DCB) Sales by Region (2027-2032) & (k units) Table 21. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2021-2026) Table 22. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2027-2032) Table 23. Global Drug-coated Balloon (DCB) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Drug-coated Balloon (DCB) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Drug-coated Balloon (DCB) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Drug-coated Balloon (DCB) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Drug-coated Balloon (DCB) Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Drug-coated Balloon (DCB) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Drug-coated Balloon (DCB) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Drug-coated Balloon (DCB) Manufacturers, Product Type & Application Table 31. Global Drug-coated Balloon (DCB) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Drug-coated Balloon (DCB) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Drug-coated Balloon (DCB) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2026) Table 38. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2027-2032) Table 39. Global Drug-coated Balloon (DCB) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 41. Global Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 42. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2026) Table 43. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2027-2032) Table 44. Global Drug-coated Balloon (DCB) Price by Type (2021-2026) & (USD/unit) Table 45. Global Drug-coated Balloon (DCB) Price by Type (2027-2032) & (USD/unit) Table 46. Global Drug-coated Balloon (DCB) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2026) Table 50. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2027-2032) Table 51. Global Drug-coated Balloon (DCB) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 53. Global Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 54. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2026) Table 55. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2027-2032) Table 56. Global Drug-coated Balloon (DCB) Price by Application (2021-2026) & (USD/unit) Table 57. Global Drug-coated Balloon (DCB) Price by Application (2027-2032) & (USD/unit) Table 58. Medtronic Company Information Table 59. Medtronic Business Overview Table 60. Medtronic Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Medtronic Drug-coated Balloon (DCB) Product Portfolio Table 62. Medtronic Recent Development Table 63. Boston Scientific Company Information Table 64. Boston Scientific Business Overview Table 65. Boston Scientific Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Boston Scientific Drug-coated Balloon (DCB) Product Portfolio Table 67. Boston Scientific Recent Development Table 68. Becton Dickinson Company Information Table 69. Becton Dickinson Business Overview Table 70. Becton Dickinson Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio Table 72. Becton Dickinson Recent Development Table 73. Biotronik Company Information Table 74. Biotronik Business Overview Table 75. Biotronik Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Biotronik Drug-coated Balloon (DCB) Product Portfolio Table 77. Biotronik Recent Development Table 78. B. Braun Company Information Table 79. B. Braun Business Overview Table 80. B. Braun Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. B. Braun Drug-coated Balloon (DCB) Product Portfolio Table 82. B. Braun Recent Development Table 83. Philips Company Information Table 84. Philips Business Overview Table 85. Philips Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Philips Drug-coated Balloon (DCB) Product Portfolio Table 87. Philips Recent Development Table 88. Abbott Company Information Table 89. Abbott Business Overview Table 90. Abbott Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Abbott Drug-coated Balloon (DCB) Product Portfolio Table 92. Abbott Recent Development Table 93. Eurocor Company Information Table 94. Eurocor Business Overview Table 95. Eurocor Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Eurocor Drug-coated Balloon (DCB) Product Portfolio Table 97. Eurocor Recent Development Table 98. Yinyi Biotech Company Information Table 99. Yinyi Biotech Business Overview Table 100. Yinyi Biotech Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio Table 102. Yinyi Biotech Recent Development Table 103. Lepu Medical Company Information Table 104. Lepu Medical Business Overview Table 105. Lepu Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Lepu Medical Drug-coated Balloon (DCB) Product Portfolio Table 107. Lepu Medical Recent Development Table 108. Grand Pharma Company Information Table 109. Grand Pharma Business Overview Table 110. Grand Pharma Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Grand Pharma Drug-coated Balloon (DCB) Product Portfolio Table 112. Grand Pharma Recent Development Table 113. Acotec Scientific Company Information Table 114. Acotec Scientific Business Overview Table 115. Acotec Scientific Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio Table 117. Acotec Scientific Recent Development Table 118. Shenqi Medical Company Information Table 119. Shenqi Medical Business Overview Table 120. Shenqi Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio Table 122. Shenqi Medical Recent Development Table 123. MicroPort Company Information Table 124. MicroPort Business Overview Table 125. MicroPort Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. MicroPort Drug-coated Balloon (DCB) Product Portfolio Table 127. MicroPort Recent Development Table 128. Zylox-Tonbridge Medical Company Information Table 129. Zylox-Tonbridge Medical Business Overview Table 130. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio Table 132. Zylox-Tonbridge Medical Recent Development Table 133. Zhejiang Barty Medical Company Information Table 134. Zhejiang Barty Medical Business Overview Table 135. Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio Table 137. Zhejiang Barty Medical Recent Development Table 138. North America Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 141. North America Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 142. North America Drug-coated Balloon (DCB) Sales Price by Type (2021-2026) & (USD/unit) Table 143. North America Drug-coated Balloon (DCB) Sales Price by Type (2027-2032) & (USD/unit) Table 144. North America Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 147. North America Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 148. North America Drug-coated Balloon (DCB) Sales Price by Application (2021-2026) & (USD/unit) Table 149. North America Drug-coated Balloon (DCB) Sales Price by Application (2027-2032) & (USD/unit) Table 150. North America Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 154. North America Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 155. North America Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 156. North America Drug-coated Balloon (DCB) Sales Price by Country (2021-2026) & (USD/unit) Table 157. North America Drug-coated Balloon (DCB) Sales Price by Country (2027-2032) & (USD/unit) Table 158. United States Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 159. Canada Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 160. Mexico Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 161. Europe Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 164. Europe Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 165. Europe Drug-coated Balloon (DCB) Sales Price by Type (2021-2026) & (USD/unit) Table 166. Europe Drug-coated Balloon (DCB) Sales Price by Type (2027-2032) & (USD/unit) Table 167. Europe Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 170. Europe Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 171. Europe Drug-coated Balloon (DCB) Sales Price by Application (2021-2026) & (USD/unit) Table 172. Europe Drug-coated Balloon (DCB) Sales Price by Application (2027-2032) & (USD/unit) Table 173. Europe Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 177. Europe Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 178. Europe Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 179. Europe Drug-coated Balloon (DCB) Sales Price by Country (2021-2026) & (USD/unit) Table 180. Europe Drug-coated Balloon (DCB) Sales Price by Country (2027-2032) & (USD/unit) Table 181. Germany Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 182. France Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 183. U.K. Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 184. Italy Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 185. Russia Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 186. Spain Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 187. Netherlands Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 188. Switzerland Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 189. Sweden Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 190. Poland Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 191. China Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (US$ Million) Table 192. China Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (US$ Million) Table 193. China Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 194. China Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 195. China Drug-coated Balloon (DCB) Sales Price by Type (2021-2026) & (USD/unit) Table 196. China Drug-coated Balloon (DCB) Sales Price by Type (2027-2032) & (USD/unit) Table 197. China Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (US$ Million) Table 198. China Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (US$ Million) Table 199. China Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 200. China Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 201. China Drug-coated Balloon (DCB) Sales Price by Application (2021-2026) & (USD/unit) Table 202. China Drug-coated Balloon (DCB) Sales Price by Application (2027-2032) & (USD/unit) Table 203. Asia Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 206. Asia Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 207. Asia Drug-coated Balloon (DCB) Sales Price by Type (2021-2026) & (USD/unit) Table 208. Asia Drug-coated Balloon (DCB) Sales Price by Type (2027-2032) & (USD/unit) Table 209. Asia Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 212. Asia Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 213. Asia Drug-coated Balloon (DCB) Sales Price by Application (2021-2026) & (USD/unit) Table 214. Asia Drug-coated Balloon (DCB) Sales Price by Application (2027-2032) & (USD/unit) Table 215. Asia Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. Asia Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 220. Asia Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 221. Asia Drug-coated Balloon (DCB) Sales Price by Country (2021-2026) & (USD/unit) Table 222. Asia Drug-coated Balloon (DCB) Sales Price by Country (2027-2032) & (USD/unit) Table 223. Japan Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 224. South Korea Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 225. India Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 226. Australia Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 227. Taiwan Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 232. SAMEA Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 233. SAMEA Drug-coated Balloon (DCB) Sales Price by Type (2021-2026) & (USD/unit) Table 234. SAMEA Drug-coated Balloon (DCB) Sales Price by Type (2027-2032) & (USD/unit) Table 235. SAMEA Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 238. SAMEA Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 239. SAMEA Drug-coated Balloon (DCB) Sales Price by Application (2021-2026) & (USD/unit) Table 240. SAMEA Drug-coated Balloon (DCB) Sales Price by Application (2027-2032) & (USD/unit) Table 241. SAMEA Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 245. SAMEA Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 246. SAMEA Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 247. SAMEA Drug-coated Balloon (DCB) Sales Price by Country (2021-2026) & (USD/unit) Table 248. SAMEA Drug-coated Balloon (DCB) Sales Price by Country (2027-2032) & (USD/unit) Table 249. Brazil Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 250. Argentina Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 251. Chile Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 252. Colombia Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 253. Peru Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 255. Israel Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 256. UAE Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 257. Turkey Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 258. Iran Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 259. Egypt Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Drug-coated Balloon (DCB) Distributors List Table 263. Drug-coated Balloon (DCB) Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Drug-coated Balloon (DCB) Image Figure 2. Global Drug-coated Balloon (DCB) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug-coated Balloon (DCB) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Coronary DCB Image Figure 5. Peripheral DCB (FP) Image Figure 6. Peripheral DCB (BTK) Image Figure 7. Global Drug-coated Balloon (DCB) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug-coated Balloon (DCB) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Dialysis Access (AVF/AVG) Image Figure 10. Femoropopliteal (FP) Image Figure 11. Below-the-Knee (BTK) Image Figure 12. Global Drug-coated Balloon (DCB) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Figure 14. Global Drug-coated Balloon (DCB) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Drug-coated Balloon (DCB) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2021-2032) Figure 17. Global Drug-coated Balloon (DCB) Sales (2021-2032) & (k units) Figure 18. Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Drug-coated Balloon (DCB) Sales YoY (2021-2032) & (k units) Figure 21. Europe Drug-coated Balloon (DCB) Sales YoY (2021-2032) & (k units) Figure 22. China Drug-coated Balloon (DCB) Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Drug-coated Balloon (DCB) Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Drug-coated Balloon (DCB) Sales YoY (2021-2032) & (k units) Figure 25. Global Drug-coated Balloon (DCB) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Drug-coated Balloon (DCB) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Drug-coated Balloon (DCB) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Drug-coated Balloon (DCB) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032) Figure 31. Global Drug-coated Balloon (DCB) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Drug-coated Balloon (DCB) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032) Figure 34. Global Drug-coated Balloon (DCB) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Drug-coated Balloon (DCB) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032) Figure 37. Global Drug-coated Balloon (DCB) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Drug-coated Balloon (DCB) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032) Figure 40. North America Drug-coated Balloon (DCB) Revenue Share by Type (2021-2032) Figure 41. North America Drug-coated Balloon (DCB) Sales Share by Type (2021-2032) Figure 42. North America Drug-coated Balloon (DCB) Revenue Share by Application (2021-2032) Figure 43. North America Drug-coated Balloon (DCB) Sales Share by Application (2021-2032) Figure 44. North America Drug-coated Balloon (DCB) Revenue Share by Country (2021-2032) Figure 45. North America Drug-coated Balloon (DCB) Sales Share by Country (2021-2032) Figure 46. Europe Drug-coated Balloon (DCB) Revenue Share by Type (2021-2032) Figure 47. Europe Drug-coated Balloon (DCB) Sales Share by Type (2021-2032) Figure 48. Europe Drug-coated Balloon (DCB) Revenue Share by Application (2021-2032) Figure 49. Europe Drug-coated Balloon (DCB) Sales Share by Application (2021-2032) Figure 50. Europe Drug-coated Balloon (DCB) Revenue Share by Country (2021-2032) Figure 51. Europe Drug-coated Balloon (DCB) Sales Share by Country (2021-2032) Figure 52. China Drug-coated Balloon (DCB) Revenue Share by Type (2021-2032) Figure 53. China Drug-coated Balloon (DCB) Sales Share by Type (2021-2032) Figure 54. China Drug-coated Balloon (DCB) Revenue Share by Application (2021-2032) Figure 55. China Drug-coated Balloon (DCB) Sales Share by Application (2021-2032) Figure 56. Asia Drug-coated Balloon (DCB) Revenue Share by Type (2021-2032) Figure 57. Asia Drug-coated Balloon (DCB) Sales Share by Type (2021-2032) Figure 58. Asia Drug-coated Balloon (DCB) Revenue Share by Application (2021-2032) Figure 59. Asia Drug-coated Balloon (DCB) Sales Share by Application (2021-2032) Figure 60. Asia Drug-coated Balloon (DCB) Revenue Share by Country (2021-2032) Figure 61. Asia Drug-coated Balloon (DCB) Sales Share by Country (2021-2032) Figure 62. SAMEA Drug-coated Balloon (DCB) Revenue Share by Type (2021-2032) Figure 63. SAMEA Drug-coated Balloon (DCB) Sales Share by Type (2021-2032) Figure 64. SAMEA Drug-coated Balloon (DCB) Revenue Share by Application (2021-2032) Figure 65. SAMEA Drug-coated Balloon (DCB) Sales Share by Application (2021-2032) Figure 66. SAMEA Drug-coated Balloon (DCB) Revenue Share by Country (2021-2032) Figure 67. SAMEA Drug-coated Balloon (DCB) Sales Share by Country (2021-2032) Figure 68. Drug-coated Balloon (DCB) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Drug-coated Balloon (DCB) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Coronary DCB
  • Peripheral DCB (FP)
  • Peripheral DCB (BTK)
Applications
  • Dialysis Access (AVF/AVG)
  • Femoropopliteal (FP)
  • Below-the-Knee (BTK)
Companies covered
  • Medtronic
  • Boston Scientific
  • Becton Dickinson
  • Biotronik
  • B. Braun
  • Philips
  • Abbott
  • Eurocor
  • Yinyi Biotech
  • Lepu Medical
  • Grand Pharma
  • Acotec Scientific
  • Shenqi Medical
  • MicroPort
  • Zylox-Tonbridge Medical
  • Zhejiang Barty Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug-coated Balloon (DCB) Market by Type
  3. 1.2.1 Global Drug-coated Balloon (DCB) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Coronary DCB
  5. 1.2.3 Peripheral DCB (FP)
  6. 1.2.4 Peripheral DCB (BTK)
  7. 1.3 Drug-coated Balloon (DCB) Market by Application
  8. 1.3.1 Global Drug-coated Balloon (DCB) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Dialysis Access (AVF/AVG)
  10. 1.3.3 Femoropopliteal (FP)
  11. 1.3.4 Below-the-Knee (BTK)
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Drug-coated Balloon (DCB) Market Dynamics
  1. 2.1 Drug-coated Balloon (DCB) Industry Trends
  2. 2.2 Drug-coated Balloon (DCB) Industry Drivers
  3. 2.3 Drug-coated Balloon (DCB) Industry Opportunities and Challenges
  4. 2.4 Drug-coated Balloon (DCB) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Drug-coated Balloon (DCB) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Drug-coated Balloon (DCB) Revenue by Region
  3. 3.2.1 Global Drug-coated Balloon (DCB) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug-coated Balloon (DCB) Revenue by Region (2021-2026)
  5. 3.2.3 Global Drug-coated Balloon (DCB) Revenue by Region (2027-2032)
  6. 3.2.4 Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Drug-coated Balloon (DCB) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Drug-coated Balloon (DCB) Sales by Region
  9. 3.4.1 Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Drug-coated Balloon (DCB) Sales by Region (2021-2026)
  11. 3.4.3 Global Drug-coated Balloon (DCB) Sales by Region (2027-2032)
  12. 3.4.4 Global Drug-coated Balloon (DCB) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Drug-coated Balloon (DCB) Revenue by Manufacturers
  2. 4.1.1 Global Drug-coated Balloon (DCB) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Drug-coated Balloon (DCB) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Drug-coated Balloon (DCB) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug-coated Balloon (DCB) Sales by Manufacturers
  6. 4.2.1 Global Drug-coated Balloon (DCB) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Drug-coated Balloon (DCB) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Drug-coated Balloon (DCB) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Drug-coated Balloon (DCB) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Drug-coated Balloon (DCB) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Drug-coated Balloon (DCB) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Drug-coated Balloon (DCB) Manufacturers, Product Type & Application
  13. 4.7 Global Drug-coated Balloon (DCB) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Drug-coated Balloon (DCB) Market CR5 and HHI
  16. 4.8.2 2025 Drug-coated Balloon (DCB) Tier 1, Tier 2, and Tier 3
5 Drug-coated Balloon (DCB) Market by Type
  1. 5.1 Global Drug-coated Balloon (DCB) Revenue by Type
  2. 5.1.1 Global Drug-coated Balloon (DCB) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Drug-coated Balloon (DCB) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Drug-coated Balloon (DCB) Sales by Type
  6. 5.2.1 Global Drug-coated Balloon (DCB) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Drug-coated Balloon (DCB) Price by Type
6 Drug-coated Balloon (DCB) Market by Application
  1. 6.1 Global Drug-coated Balloon (DCB) Revenue by Application
  2. 6.1.1 Global Drug-coated Balloon (DCB) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Drug-coated Balloon (DCB) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Drug-coated Balloon (DCB) Sales by Application
  6. 6.2.1 Global Drug-coated Balloon (DCB) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Drug-coated Balloon (DCB) Price by Application
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Drug-coated Balloon (DCB) Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Boston Scientific
  8. 7.2.1 Boston Scientific Company Information
  9. 7.2.2 Boston Scientific Business Overview
  10. 7.2.3 Boston Scientific Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
  12. 7.2.5 Boston Scientific Recent Developments
  13. 7.3 Becton Dickinson
  14. 7.3.1 Becton Dickinson Company Information
  15. 7.3.2 Becton Dickinson Business Overview
  16. 7.3.3 Becton Dickinson Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
  18. 7.3.5 Becton Dickinson Recent Developments
  19. 7.4 Biotronik
  20. 7.4.1 Biotronik Company Information
  21. 7.4.2 Biotronik Business Overview
  22. 7.4.3 Biotronik Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biotronik Drug-coated Balloon (DCB) Product Portfolio
  24. 7.4.5 Biotronik Recent Developments
  25. 7.5 B. Braun
  26. 7.5.1 B. Braun Company Information
  27. 7.5.2 B. Braun Business Overview
  28. 7.5.3 B. Braun Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 B. Braun Drug-coated Balloon (DCB) Product Portfolio
  30. 7.5.5 B. Braun Recent Developments
  31. 7.6 Philips
  32. 7.6.1 Philips Company Information
  33. 7.6.2 Philips Business Overview
  34. 7.6.3 Philips Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Philips Drug-coated Balloon (DCB) Product Portfolio
  36. 7.6.5 Philips Recent Developments
  37. 7.7 Abbott
  38. 7.7.1 Abbott Company Information
  39. 7.7.2 Abbott Business Overview
  40. 7.7.3 Abbott Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Abbott Drug-coated Balloon (DCB) Product Portfolio
  42. 7.7.5 Abbott Recent Developments
  43. 7.8 Eurocor
  44. 7.8.1 Eurocor Company Information
  45. 7.8.2 Eurocor Business Overview
  46. 7.8.3 Eurocor Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Eurocor Drug-coated Balloon (DCB) Product Portfolio
  48. 7.8.5 Eurocor Recent Developments
  49. 7.9 Yinyi Biotech
  50. 7.9.1 Yinyi Biotech Company Information
  51. 7.9.2 Yinyi Biotech Business Overview
  52. 7.9.3 Yinyi Biotech Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
  54. 7.9.5 Yinyi Biotech Recent Developments
  55. 7.10 Lepu Medical
  56. 7.10.1 Lepu Medical Company Information
  57. 7.10.2 Lepu Medical Business Overview
  58. 7.10.3 Lepu Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
  60. 7.10.5 Lepu Medical Recent Developments
  61. 7.11 Grand Pharma
  62. 7.11.1 Grand Pharma Company Information
  63. 7.11.2 Grand Pharma Business Overview
  64. 7.11.3 Grand Pharma Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
  66. 7.11.5 Grand Pharma Recent Developments
  67. 7.12 Acotec Scientific
  68. 7.12.1 Acotec Scientific Company Information
  69. 7.12.2 Acotec Scientific Business Overview
  70. 7.12.3 Acotec Scientific Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
  72. 7.12.5 Acotec Scientific Recent Developments
  73. 7.13 Shenqi Medical
  74. 7.13.1 Shenqi Medical Company Information
  75. 7.13.2 Shenqi Medical Business Overview
  76. 7.13.3 Shenqi Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
  78. 7.13.5 Shenqi Medical Recent Developments
  79. 7.14 MicroPort
  80. 7.14.1 MicroPort Company Information
  81. 7.14.2 MicroPort Business Overview
  82. 7.14.3 MicroPort Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 MicroPort Drug-coated Balloon (DCB) Product Portfolio
  84. 7.14.5 MicroPort Recent Developments
  85. 7.15 Zylox-Tonbridge Medical
  86. 7.15.1 Zylox-Tonbridge Medical Company Information
  87. 7.15.2 Zylox-Tonbridge Medical Business Overview
  88. 7.15.3 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
  90. 7.15.5 Zylox-Tonbridge Medical Recent Developments
  91. 7.16 Zhejiang Barty Medical
  92. 7.16.1 Zhejiang Barty Medical Company Information
  93. 7.16.2 Zhejiang Barty Medical Business Overview
  94. 7.16.3 Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
  96. 7.16.5 Zhejiang Barty Medical Recent Developments
8 North America
  1. 8.1 North America Drug-coated Balloon (DCB) Market Size by Type
  2. 8.1.1 North America Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
  3. 8.1.2 North America Drug-coated Balloon (DCB) Sales by Type (2021-2032)
  4. 8.1.3 North America Drug-coated Balloon (DCB) Price by Type (2021-2032)
  5. 8.2 North America Drug-coated Balloon (DCB) Market Size by Application
  6. 8.2.1 North America Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
  7. 8.2.2 North America Drug-coated Balloon (DCB) Sales by Application (2021-2032)
  8. 8.2.3 North America Drug-coated Balloon (DCB) Price by Application (2021-2032)
  9. 8.3 North America Drug-coated Balloon (DCB) Market Size by Country
  10. 8.3.1 North America Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Drug-coated Balloon (DCB) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Drug-coated Balloon (DCB) Market Size by Type
  2. 9.1.1 Europe Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Drug-coated Balloon (DCB) Sales by Type (2021-2032)
  4. 9.1.3 Europe Drug-coated Balloon (DCB) Price by Type (2021-2032)
  5. 9.2 Europe Drug-coated Balloon (DCB) Market Size by Application
  6. 9.2.1 Europe Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Drug-coated Balloon (DCB) Sales by Application (2021-2032)
  8. 9.2.3 Europe Drug-coated Balloon (DCB) Price by Application (2021-2032)
  9. 9.3 Europe Drug-coated Balloon (DCB) Market Size by Country
  10. 9.3.1 Europe Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Drug-coated Balloon (DCB) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Drug-coated Balloon (DCB) Market Size by Type
  2. 10.1.1 China Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
  3. 10.1.2 China Drug-coated Balloon (DCB) Sales by Type (2021-2032)
  4. 10.1.3 China Drug-coated Balloon (DCB) Price by Type (2021-2032)
  5. 10.2 China Drug-coated Balloon (DCB) Market Size by Application
  6. 10.2.1 China Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
  7. 10.2.2 China Drug-coated Balloon (DCB) Sales by Application (2021-2032)
  8. 10.2.3 China Drug-coated Balloon (DCB) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug-coated Balloon (DCB) Market Size by Type
  2. 11.1.1 Asia Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Drug-coated Balloon (DCB) Sales by Type (2021-2032)
  4. 11.1.3 Asia Drug-coated Balloon (DCB) Price by Type (2021-2032)
  5. 11.2 Asia Drug-coated Balloon (DCB) Market Size by Application
  6. 11.2.1 Asia Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Drug-coated Balloon (DCB) Sales by Application (2021-2032)
  8. 11.2.3 Asia Drug-coated Balloon (DCB) Price by Application (2021-2032)
  9. 11.3 Asia Drug-coated Balloon (DCB) Market Size by Country
  10. 11.3.1 Asia Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Drug-coated Balloon (DCB) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug-coated Balloon (DCB) Market Size by Type
  2. 12.1.1 SAMEA Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Drug-coated Balloon (DCB) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Drug-coated Balloon (DCB) Price by Type (2021-2032)
  5. 12.2 SAMEA Drug-coated Balloon (DCB) Market Size by Application
  6. 12.2.1 SAMEA Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Drug-coated Balloon (DCB) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Drug-coated Balloon (DCB) Price by Application (2021-2032)
  9. 12.3 SAMEA Drug-coated Balloon (DCB) Market Size by Country
  10. 12.3.1 SAMEA Drug-coated Balloon (DCB) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Drug-coated Balloon (DCB) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Drug-coated Balloon (DCB) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Drug-coated Balloon (DCB) Value Chain Analysis
  2. 13.1.1 Drug-coated Balloon (DCB) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Drug-coated Balloon (DCB) Production Mode & Process
  6. 13.2 Drug-coated Balloon (DCB) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Drug-coated Balloon (DCB) Distributors
  9. 13.2.3 Drug-coated Balloon (DCB) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research